ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 01/09/2025 at 17:44, 13 days 15 hours ago

Abivax franchit une étape clé dans le recrutement de l’essai de phase 3 ABTECT
Abivax franchit une étape clé dans le recrutement de l'essai de phase 3 ABTECT pour le traitement de la RCH. Objectif de recrutement proche de 82%. Premiers résultats attendus en 2025

Abivax Recrutement Phase 3 ABTECT RCH
BRIEF

published on 01/09/2025 at 17:40, 13 days 15 hours ago

Abivax franchit une étape clé dans le recrutement de l'essai de phase 3 ABTECT

Abivax Obefazimod Rectocolite Hémorragique Essai De Phase 3 Résultats Cliniques
BRIEF

published on 01/09/2025 at 17:40, 13 days 15 hours ago

Abivax Reaches Key Enrollment Milestone in Phase 3 ABTECT Trial

Abivax Obefazimod Ulcerative Colitis Phase 3 Trial Clinical Results
PRESS RELEASE

published on 01/09/2025 at 17:35, 13 days 15 hours ago

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
Abivax achieves key milestone in Phase 3 ABTECT trial enrollment with 82% of target participants enrolled for evaluating obefazimod in ulcerative colitis, aiming for NDA submission by H2 2026

Abivax Obefazimod Ulcerative Colitis Phase 3 ABTECT Trial
BRIEF

published on 12/23/2024 at 22:10, 30 days 10 hours ago

Abivax Announces Board Resignation

Abivax Obefazimod Board Resignation Truffle Capital Philippe Pouletty
BRIEF

published on 12/23/2024 at 22:10, 30 days 10 hours ago

Abivax annonce la démission de son conseil d'administration

Abivax Obefazimod Démission Du Conseil D'administration La Capitale De La Truffe Philippe Pouletty
PRESS RELEASE

published on 12/23/2024 at 22:05, 30 days 10 hours ago

Abivax annonce une modification de la composition de son Conseil d'administration
Abivax annonce la démission du Dr Philippe Pouletty en tant qu'administrateur et recherche un nouveau membre du Conseil d'administration. Plus d'informations sur www.abivax.com

Abivax Conseil D'administration Rectocolite Hémorragique Démission Maladies Inflammatoires
PRESS RELEASE

published on 12/23/2024 at 22:05, 30 days 10 hours ago

Abivax annonce une modification de la composition de son Conseil d'administration
Abivax annonce la démission du Dr. Philippe Pouletty en tant qu'administrateur et recherche un nouveau membre du Conseil d'administration pour soutenir le développement de thérapies. Détails sur www.abivax.com

Innovation Abivax Conseil D'administration Démission Thérapies
PRESS RELEASE

published on 12/23/2024 at 22:05, 30 days 10 hours ago

Abivax Announces a Change to the Composition of its Board of Directors
Abivax announces a change in its Board of Directors composition as Dr. Philippe Pouletty resigns due to new appointment. The company expresses gratitude for his contributions

Board Of Directors Resignation Abivax Therapeutics Dr. Philippe Pouletty
BRIEF

published on 12/18/2024 at 18:05, 1 month 4 days ago

ABIVAX : Capital social et droits de vote au 30 novembre 2024

Investissement Euronext Paris Droits De Vote Capital Social Abivax

Published on 01/23/2025 at 06:00, 2 hours 46 minutes ago

The Now Corporation (OTC:NWPN) In Conjunction With Subsidiary Green Rain Solar Inc., Launch a Visionary Video Showcasing Solar Energy Solutions
Published on 01/23/2025 at 02:30, 6 hours 16 minutes ago

Armory Mining Corp. Closes LIFE Offering
Published on 01/23/2025 at 02:00, 6 hours 46 minutes ago

West Mining Options Kena Property to Upside Gold Corp
Published on 01/23/2025 at 02:00, 6 hours 46 minutes ago

Inspire Veterinary Partners Announces 1-for-25 Reverse Stock Split
Published on 01/23/2025 at 00:00, 8 hours 46 minutes ago

Onco-Innovations Enters into LOI with Inka Health to Implement AI Technology Toward Cancer Detection and Drug Development

View all ACCESSWIRE

Published on 01/23/2025 at 08:38, 8 minutes ago

Current study shows: (Semi-)professional investors are increasingly concentrating on impact investing
Published on 01/23/2025 at 08:30, 16 minutes ago

2G Energy remains clearly on growth course
Published on 01/23/2025 at 08:15, 31 minutes ago

Surge in Swiss Debt Restructuring Moratoriums in 2023
Published on 01/23/2025 at 08:00, 46 minutes ago

R.E.A. Holdings plc: Trading update
Published on 01/23/2025 at 08:00, 46 minutes ago

SWEF: December 2024 NAV

View all EQS

Published on 01/23/2025 at 07:00, 1 hour 46 minutes ago

2024 : Une nouvelle année de croissance. Chiffre d'affaires 880 M€ (+10 %)
Published on 01/23/2025 at 07:00, 1 hour 46 minutes ago

2024: Another year of growth. Annual sales: €880m (+10%)
Published on 01/22/2025 at 17:45, 15 hours 1 minute ago

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT
Published on 01/22/2025 at 17:14, 15 hours 32 minutes ago

VOGO : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial.
Published on 01/22/2025 at 07:04, 1 day 1 hour ago

Gimv launches strategy to accelerate its growth

View all LES ECHOS COMFI WIRE

News